By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

Company News
Celsion Corporation (CLSN) Announces Continuing Positive Data From Its Phase 2 DIGNITY Study In Breast Cancer 7/6/2015 7:22:17 AM
Celsion Corporation (CLSN) To Present At Cantor Fitzgerald's Inaugural Healthcare Conference On July 8, 2015 7/1/2015 7:43:51 AM
ASCO15: Celsion Corporation (CLSN) Presents GEN-1 Immunotherapy Phase 1b Results In Recurrent Ovarian Cancer At ASCO 2015 6/1/2015 6:39:48 AM
Celsion Corporation (CLSN) Announces $8 Million At-The-Market Registered Direct Offering 5/28/2015 7:24:48 AM
Celsion Corporation (CLSN) Announces Potent, Durable Preclinical Lung Expression Data For Its Novel TheraSilence RNA Program 5/21/2015 6:45:28 AM
Celsion Corporation (CLSN) Announces Publication Of Preclinical Data Demonstrating Lung Specific Delivery of microRNA-145 Inhibitor Using Its Novel TheraSilence Platform 5/15/2015 6:18:02 AM
Celsion Corporation (CLSN) Announces ASCO 2015 GEN-1 Immunotherapy Phase 1b Results In Ovarian Cancer Presentation 5/14/2015 10:58:35 AM
Celsion Corporation (CLSN) Reports First Quarter 2015 Financial Results And Provides Business Update 5/12/2015 10:27:42 AM
Celsion Corporation (CLSN) To Hold First Quarter 2015 Financial Results Conference Call On Tuesday, May 12, 2015 5/5/2015 7:42:46 AM
Celsion Corporation (CLSN) Expands Clinical Development Plan For GEN-1 IL-12 Immunotherapy Program In Ovarian Cancer 4/29/2015 6:59:35 AM